Mesoblast Limited (ASX:MSB)
2.020
-0.130 (-6.05%)
Mar 28, 2025, 4:10 PM AEST
Mesoblast Revenue
Mesoblast had revenue of $3.16M USD in the half year ending December 31, 2024, a decrease of -7.77%. This brings the company's revenue in the last twelve months to $5.67M, down -24.07% year-over-year. In the fiscal year ending June 30, 2024, Mesoblast had annual revenue of $5.90M, down -21.32%.
Revenue (ttm)
$5.67M
Revenue Growth
-24.07%
P/S Ratio
247.00
Revenue / Employee
$77.67K
Employees
73
Market Cap
2.57B AUD
Revenue Chart
* This company reports financials in USD.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Jun 30, 2024 | 5.90M | -1.60M | -21.32% |
Jun 30, 2023 | 7.50M | -2.71M | -26.54% |
Jun 30, 2022 | 10.21M | 2.78M | 37.36% |
Jun 30, 2021 | 7.43M | -24.72M | -76.88% |
Jun 30, 2020 | 32.16M | 15.43M | 92.30% |
Jun 30, 2019 | Pro | Pro | Pro |
Jun 30, 2018 | Pro | Pro | Pro |
Jun 30, 2017 | Pro | Pro | Pro |
Jun 30, 2016 | Pro | Pro | Pro |
Jun 30, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionMesoblast News
- 3 days ago - Mesoblast Ltd (MESO) Announces FDA Approval and U.S. ... - GuruFocus
- 3 days ago - Ryoncil® is Now Available for Purchase in the United States - GlobeNewsWire
- 16 days ago - Ryoncil® Product Information Now Available in All Four Major Drug Pricing Compendia in United States - GlobeNewsWire
- 18 days ago - Mesoblast CEO to Deliver Featured Presentation at ISCT North America Virtual Town Hall - GlobeNewsWire
- 23 days ago - Mesoblast Ltd (MESO) Joins S&P/ASX 200 Index - GuruFocus
- 24 days ago - ASX 200 LIVE: Oil pushes Santos, Woodside lower; Air NZ CEO Greg Foran resigns; Mesoblast joins ASX 200. - The Australian Financial Review
- 4 weeks ago - Mesoblast Limited (MESO) Q2 2025 Earnings Call Transcript - Seeking Alpha
- 4 weeks ago - Mesoblast Limited 2024 Q4 - Results - Earnings Call Presentation - Seeking Alpha